HI
NVAX icon

HBK Investments’s Novavax NVAX Stock Holding History

HBK Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-14,644
Closed -$2.07M – 1072
2015
Q3 		$2.07M Buy
+14,644
New +$3.28M 0.02% 408
2015
Q2 		– Sell
-2,109
Closed -$349K – 1047
2015
Q1 		$349K Buy
+2,109
New +$342K ﹤0.01% 832
2014
Q2 		– Sell
-11,833
Closed -$1.07M – 1001
2014
Q1 		$1.07M Buy
11,833
+7,917
+202% +$884K 0.02% 469
2013
Q4 		$401K Buy
+3,916
New +$277K 0.01% 705

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HBK Investments's NVAX Position: Q4 2015 in Review

HBK Investments sold out of Novavax (NVAX) in Q4 2015, closing a stake of 14,644 shares — an estimated $2.07M sold.

HBK Investments first reported a position in NVAX in Q4 2013 and held it in 4 quarters. The position peaked at $2.07M in Q3 2015. 173 funds tracked by Wall St. Rank hold NVAX as of Q4 2015.

  • HBK Investments reported no remaining Novavax position as of Q4 2015 after selling out during the quarter.
  • HBK Investments sold 14,644 Novavax shares in Q4 2015, an estimated $2.07M.
  • HBK Investments first reported a position in Novavax in Q4 2013 and held it in 4 quarters.
  • HBK Investments's Novavax position peaked at $2.07M in Q3 2015.
  • 173 funds tracked by Wall St. Rank held Novavax as of Q4 2015.

Based on HBK Investments's 13F filing for Q4 2015, filed 16 Feb 2016.